Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR4A2 | P43354 | 3/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | NCEH1 | Q6PIU2 | 2/20 | 0.46 |
| ▸ | CA12 | O43570 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | CA7 | P43166 | 1/20 | 0.46 |
| ▸ | CA9 | Q16790 | 1/20 | 0.46 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 3/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.44 |
| ▸ | ATM | Q13315 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | HPGD | P15428 | 2/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL796905 | 0.94 | MEN1 (0.44) | NR4A2MAPK1LMNANCEH1CA12 | |
| SCHEMBL796328 | 0.88 | KDM4E (0.40) | NR4A2MAPK1LMNANCEH1CA12 | |
| SCHEMBL797153 | 0.82 | MEN1 (0.44) | MAPK1CA12CA1CA2CA7 | |
| SCHEMBL797383 | 0.81 | KMT2A (0.43) | CA12CA1CA2CA7CA9 | |
| SCHEMBL797755 | 0.79 | KDM4E (0.50) | NCEH1MEN1KMT2AKDM4EALDH1A1 | |
| SCHEMBL10079131 | 0.79 | MEN1 (0.43) | MAPK1LMNACA12CA1CA2 | |
| SCHEMBL10079130 | 0.78 | MEN1 (0.42) | MAPK1LMNACA12CA1CA2 | |
| SCHEMBL30881977 | 0.78 | ALDH1A1 (0.52) | LMNACA12CA1CA2CA7 | |
| SCHEMBL12002083 | 0.78 | ALDH1A1 (0.56) | LMNACA12CA1CA2CA7 | |
| SCHEMBL70573 | 0.76 | CA12 (0.60) | NR4A2MAPK1LMNANCEH1CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050240061-A1 | Functional thin film | JAPAN SCIENCE AND TECHNOLOGY AGENCY | 2005-10-27 | — | — | US | disclosed |
| EP-1493796-A1 | FUNCTIONAL THIN FILM | Japan Science and Technology Agency (JP) | 2005-01-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050240061-A1 | Functional thin film | H1-10, H1-0, H1-2 | NR4A2 1628/4885MAPK1 1864/4885LMNA 1771/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.